Hi immi101,
You're absolutely welcome! Another positive I didn't mention earlier was the licensing deal done with Professor Masters in the UK for ATH434 for Alzheimers disease. I have no clue how that is progressing. From memory, he has been working with our formula since 2022. A surprise announcement from that trial would be most welcome any time this year also. I am hoping for all of us here, especially the very long-term holders that we are successful. I hope you all stay well....
Stockman
Ann: Notice Under Section 708A, page-20
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.002(40.0%) |
Mkt cap ! $36.71M | |||
| Open | High | Low | Value | Volume |
| 0.6¢ | 0.7¢ | 0.6¢ | $980.8K | 154.3M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4519008 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 36825074 | 29 |
View Market Depth
| Last trade - 16.10pm 17/07/2024 (20 minute delay) ? |
| ATH (ASX) Chart |